12 niðurstöður
BACKGROUND OF THE INVENTION
The invention mainly relates to a new use of an acetone extract, chloroform extract or hexane extract of Angelicae sinensis and the active components purified therefrom in the treatment of cancers.
Cancers are abnormal cell proliferations that result from the accumulation
The present invention relates to a specific compound homocysteine thiolactone perchlorate and a method of making same. Homocysteine is HSCH.sub.2 CH.sub.2 CH(NH.sub.2)COOH and the thiolactone is shown below. Of the known salts of homocysteine thiolactone, the present perchlorate is deemed unique in
BACKGROUND
In other studies which we have made, we have considered the effects of glucosinolates. Glucosinolates are naturally-occurring constituents of cruciferous vegetables (Tookey, H. L., VanEtten, C. H. and Daxenbichler, M. E. (1980) Glucosinolates. In liener, I. E. (ed.), Toxic Constituents of
BACKGROUND
In other studies which we have made, we have considered the effects of glucosinolates. Glucosinolates are naturally-occurring constituents of cruciferous vegetables (Tookey, H. L., VanEtten, C. H. and Daxenbichler, M. E. (1980) Glucosinolates. In Liener, I. E. (ed.), Toxic Constituents of
FIELD OF INVENTION
The present invention discloses an adjuvant comprising a surfactant and the total lipid extract of the BCG mycobacterium as well as the apolar fraction thereof and a vaccine comprising said adjuvant and an antigenic substance.
BACKGROUND OF THE INVENTION
The first vaccines
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Stage Application of International Application No. PCT/CN2013/075235 filed on May 7, 2013, and published in Chinese as WO 2013/174207 A1 on Nov. 28, 2013. This application claims priority to Chinese Application No.
FIELD OF THE INVENTION
The present invention relates to a protein tyrosine phosphatase inhibitor, to method for preparing the same, and to use thereof in the manufacture of a pharmaceutical composition for the treatment and prevention of diabetes, obesity and cancers.
BACKGROUND OF THE
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a tumor radiation probe, particularly to a molecule similar to .sup.18F-FLT, and more particularly to [.sup.123I]-IaraU of iodine-123 marker thymidine (FLT) analogue.
2. Description of Related Art
Development of
BACKGROUND OF THE INVENTION
This invention relates to newly synthesized platinum complexes with hydrophobic properties. The use of liposomes incorporating these new and previously synthesized complexes in anti-tumor chemotherapy is also described.
Cis-platinum (CDDP) is a highly effective drug in
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to novel glycoproteins obtained from an extract or a supernatant of culture medium of reticulo-endothelial cells, lymphoblasts, leukemia cells or fibroblasts of warm-blooded animals, processes for their production and
BACKGROUND OF THE INVENTION
1) Field of the Invention
This invention relates to water-soluble extracts from a plant of Solanum genus, the preparation processes thereof, and pharmaceutical compositions comprising the same.
2) Description of the Related Art
Cancer is one of the major causes of human
The following examples illustrate the present invention, but it is to be understood that they are given for the purpose of illustration and not limitation.
EXAMPLE 1
A medium (100 l) containing 6.0% soluble starch, 4.0% cotton seed meal, 0.2% (NH.sub.4).sub.2 SO.sub.4, 0.1% yeast extract, 0.2%